(Q35115487)

6 August 2017

0 references

1 reference

title

Pittsburgh compound B retention and progression of cognitive status--a meta-analysis (English)

1 reference

6 August 2017

main subject

Pittsburgh compound B

1 reference

X Chen

1

1 reference

6 August 2017

M Li

2

1 reference

6 August 2017

S Wang

3

1 reference

6 August 2017

H Zhu

4

1 reference

6 August 2017

Y Xiong

5

1 reference

6 August 2017

X Liu

6

1 reference

6 August 2017

publication date

24 February 2014

1 reference

European Journal of Neurology

6 August 2017

published in

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

1060-1067

1 reference

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

6 August 2017

cites work

1 reference

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain

21 January 2018

1 reference

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

21 January 2018

1 reference

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects

21 January 2018

1 reference

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study

21 January 2018

1 reference

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

21 January 2018

1 reference

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease

21 January 2018

1 reference

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

21 January 2018

1 reference

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

21 January 2018

1 reference

Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data

21 January 2018

1 reference

Amyloid imaging in mild cognitive impairment subtypes.

21 January 2018

1 reference

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12398

1 reference

6 August 2017

1 reference